Indian pharma manufacturers are pushing for input price caps as raw material costs surge sharply. Smaller companies warn that without support, rising expenses and tight drug price controls could disrupt medicine supply.
Ajanta Pharma, Sun Pharma, and Lupin are in focus as Ozempic Patent Expiry drives surge in pharma stocks ahead of launch, with companies gearing up for semaglutide generics in the fast-growing diabetes and weight-loss market.
AstraZeneca Pharma India has received regulatory approval for Durvalumab for liver cancer treatment in India, marking a significant step in expanding cancer care options.
.png)
Lupin is sharpening its US growth strategy by focusing on complex generics and biosimilars, aiming to tap higher-margin opportunities in the American pharmaceutical market as competition intensifies in traditional generics.
Zydus Lifesciences has received USFDA approval for Cevimeline Hydrochloride Capsules 30 mg, the generic version of Evoxac used to treat dry mouth linked to Sjögren’s syndrome, strengthening the company’s presence in the U.S. generics market.
Shilpa Biologicals and partner mAbTree Biologics AG secured FDA Orphan Drug Designation for a novel monoclonal antibody targeting Essential Thrombocythemia and Polycythemia Vera, marking a key step toward new treatments for rare blood cancers.
.png)
India’s drug regulator has barred pharmaceutical companies from promoting weight-loss drugs, warning against direct and surrogate advertising.
The Ministry of Health and Family Welfare (MoHFW) has published a draft Gazette notification proposing an amendment to the Drugs Rules, 1945, to make changes to the requirements of testing of blood products.
AbbVie reported encouraging Phase 1 results for its experimental obesity therapy ABBV-295, showing meaningful weight loss and a favorable safety profile in adults during a 12–13 week clinical study.
Lupin Ltd's Ankleshwar plant receives two observations from the U.S. FDA after inspection. The company promises to address the issues while adhering to CGMP standards for quality and safety.
, CDSCO.jpg)